Cardiovascular Complications in Children With COVID 19
Prevalance of Cardiovascular Complications in Children With COVID 19 in Assuit University Children Hospital
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Prevalance of cardiovascular complications in children with COVID 19 in Assuit university children hospital
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 22, 2023
CompletedFirst Posted
Study publicly available on registry
October 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedOctober 24, 2023
October 1, 2023
11 months
October 22, 2023
October 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalance of cardiovascular complications in children with COVID 19
estimate the prevalence of cardiovascular complications among pediatric patients with covid 19 in Isolation Unit , Chest unit , and Cardiology unit in Assiut University Children Hospital
Baseline
Interventions
diagnostic tool
Eligibility Criteria
All patients with covid 19 confirmed with PCR from January 2023 till 31 december 2023
You may qualify if:
- Patient less than 18 years old Presented with COVID 19
You may not qualify if:
- Not presented with covid19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Das BB, Akam-Venkata J, Abdulkarim M, Hussain T. Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C. Children (Basel). 2022 Jul 16;9(7):1061. doi: 10.3390/children9071061.
PMID: 35884045BACKGROUND
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
October 22, 2023
First Posted
October 24, 2023
Study Start
October 1, 2023
Primary Completion
September 1, 2024
Study Completion
October 1, 2024
Last Updated
October 24, 2023
Record last verified: 2023-10